US approves key weight-loss pill

America’s Food and Drug Administration has approved a new weight-loss drug from Vivus that many doctors consider the most effective therapy in a new generation of anti-obesity pills designed to help patients safely shed pounds.

US approves key weight-loss pill

America’s Food and Drug Administration has approved a new weight-loss drug from Vivus that many doctors consider the most effective therapy in a new generation of anti-obesity pills designed to help patients safely shed pounds.

The agency cleared the pill Qsymia for adults who are obese or overweight and have at least one weight-related condition such as high blood pressure, diabetes or high cholesterol.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited